THU586 Lipid Species In Non-alcoholic Fatty Liver Disease (NAFLD) In Type 1 Diabetes

Disclosure: A. Taiwo: None. H. Thakker: None. J. Maschek: None. J. Cox: None. S. Summers: Owner/Co-Owner; Self; Centaurus Therapeutics. D. Jalal: None. W. Sivitz: None. A. Dokun: None. B. Chaurasia: None. Background: Non-alcoholic fatty liver disease (NAFLD) is characterized by steatosis at an early...

Descripción completa

Detalles Bibliográficos
Autores principales: Taiwo, Adeyinka, Thakker, Himani, Maschek, John, Cox, James, Summers, Scott, Jalal, Diana, Sivitz, William, Dokun, Ayotunde, Chaurasia, Bhagirath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554222/
http://dx.doi.org/10.1210/jendso/bvad114.584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554222/
http://dx.doi.org/10.1210/jendso/bvad114.584

Ejemplares similares